Combining a standard chemotherapy drug with a second drug that stops cells from dividing improves both the survival and response rates for those with advanced cervical cancer, a new study by UT Southwestern Medical Center cancer researchers finds.

The cancer-fighting cocktail, which combines the chemotherapy drug cisplatin with pemetrexed – an agent that stops cancer cells from dividing – showed promising results for advanced, persistent, or recurrent cervical cancer.

READ FULL ARTICLE Curated publisher From Topix